Study to Evaluate Efficacy and Safety in Chinese Patients With Late Onset Pompe Disease With Alglucosidase Alfa Treatmen
Clinical trial NCT04676373 · COMPLETED
Trial details
- NCT number
- NCT04676373
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-10
- Primary completion
- 2024-07-25
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.